Rosetta Stone 2014 Annual Report Download - page 64
Download and view the complete annual report
Please find page 64 of the 2014 Rosetta Stone annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62 -
63 -
64 -
65 -
66 -
67 -
68 -
69 -
70 -
71 -
72 -
73 -
74 -
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
-
198
-
199
-
200
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
 |
 |
Table of Contents
Net loss
$ (73,706)
$ (16,134)
$ (33,985)
Adjustments to reconcile net loss to cash provided by operating activities:
Stock-based compensation expense
6,762
9,241
8,009
Loss on foreign currency transactions
1,171
—
—
Bad debt expense
2,405
1,420
1,820
Depreciation and amortization
13,904
9,635
8,077
Deferred income tax (benefit) expense
(7,667)
(3,869)
25,953
Loss on disposal of equipment
184
278
783
Amortization of debt issuance costs
21
—
—
Loss on impairment
20,333
—
—
Net change in:
Restricted cash
(13)
(37)
1
Accounts receivable
(16,478)
(9,477)
309
Inventory
341
(108)
185
Deferred sales commissions
(7,268)
(4,245)
(764)
Prepaid expenses and other current assets
1,844
(878)
1,869
Income tax receivable
(147)
827
6,515
Other assets
446
(68)
226
Accounts payable
8,394
3,702
(1,240)
Accrued compensation
(4,494)
(897)
5,093
Other current liabilities
11,318
4,250
635
Other long term liabilities
459
481
(99)
Deferred revenue
48,864
13,947
11,514
Net cash provided by operating activities
6,673
8,068
34,901
Purchases of property and equipment
(9,736)
(8,941)
(4,187)
Proceeds from sales of available-for-sale securities
—
—
9,711
Decrease (increase) in restricted cash related to Vivity Labs acquisition
12,314
(12,314)
—
Acquisitions, net of cash acquired
(41,687)
(25,675)
—
Net cash (used in) provided by investing activities
(39,109)
(46,930)
5,524
Proceeds from the exercise of stock options
669
2,457
862
Repurchase of shares from exercised stock options
—
(1,040)
—
Purchase of treasury stock
—
(11,435)
—
Proceeds from equity offering, net of issuance costs
—
(228)
—
Payment of financing fees
(381)
—
—
Payments under capital lease obligations
(593)
(241)
(215)
Net cash (used in) provided by financing activities
(305)
(10,487)
647
(Decrease) increase in cash and cash equivalents
(32,741)
(49,349)
41,072
Effect of exchange rate changes in cash and cash equivalents
(1,427)
(16)
602
Net (decrease) increase in cash and cash equivalents
(34,168)
(49,365)
41,674
Cash and cash equivalents—beginning of year
98,825
148,190
106,516
Cash and cash equivalents—end of year
$ 64,657
$ 98,825
$ 148,190
Cash paid during the periods for:
Interest
$ 211
$ 18
$ —
Income taxes
$ 1,722
$ 3,290
$ 4,040
Noncash financing and investing activities:
Accrued purchase price of business acquisition
$ —
$ 3,375
$ —
Accrued liability for purchase of property and equipment
$ 561
$ 192
$ 1,228
Equipment acquired under capital lease
$ —
$ 702
$ —